nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—CALM1—Alzheimer's disease	0.206	0.461	CbGaD
Trifluoperazine—HTR6—Alzheimer's disease	0.186	0.416	CbGaD
Trifluoperazine—SIGMAR1—Donepezil—Alzheimer's disease	0.183	0.586	CbGbCtD
Trifluoperazine—HTR2A—Donepezil—Alzheimer's disease	0.072	0.23	CbGbCtD
Trifluoperazine—DRD2—Memantine—Alzheimer's disease	0.0575	0.184	CbGbCtD
Trifluoperazine—HTR2A—Alzheimer's disease	0.0548	0.122	CbGaD
Trifluoperazine—HTR2C—choroid plexus—Alzheimer's disease	0.00671	0.122	CbGeAlD
Trifluoperazine—Drooling—Donepezil—Alzheimer's disease	0.00376	0.0444	CcSEcCtD
Trifluoperazine—Cogwheel rigidity—Rivastigmine—Alzheimer's disease	0.00367	0.0433	CcSEcCtD
Trifluoperazine—HTR2A—choroid plexus—Alzheimer's disease	0.00337	0.0614	CbGeAlD
Trifluoperazine—Drooling—Rivastigmine—Alzheimer's disease	0.00334	0.0395	CcSEcCtD
Trifluoperazine—HTR2A—locus ceruleus—Alzheimer's disease	0.00208	0.0379	CbGeAlD
Trifluoperazine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00197	0.0359	CbGeAlD
Trifluoperazine—Retinal disorder—Rivastigmine—Alzheimer's disease	0.00188	0.0222	CcSEcCtD
Trifluoperazine—Hyperpyrexia—Rivastigmine—Alzheimer's disease	0.0018	0.0213	CcSEcCtD
Trifluoperazine—HTR2A—cerebellar cortex—Alzheimer's disease	0.0017	0.0309	CbGeAlD
Trifluoperazine—S100A4—embryo—Alzheimer's disease	0.00167	0.0304	CbGeAlD
Trifluoperazine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00166	0.0302	CbGeAlD
Trifluoperazine—CALY—telencephalon—Alzheimer's disease	0.00157	0.0287	CbGeAlD
Trifluoperazine—Parkinsonism—Memantine—Alzheimer's disease	0.00151	0.0178	CcSEcCtD
Trifluoperazine—DRD2—telencephalic ventricle—Alzheimer's disease	0.0015	0.0273	CbGeAlD
Trifluoperazine—Parkinsonism—Rivastigmine—Alzheimer's disease	0.00147	0.0174	CcSEcCtD
Trifluoperazine—Neuroleptic malignant syndrome—Donepezil—Alzheimer's disease	0.00147	0.0174	CcSEcCtD
Trifluoperazine—Hyperreflexia—Rivastigmine—Alzheimer's disease	0.00145	0.0171	CcSEcCtD
Trifluoperazine—Sudden death—Memantine—Alzheimer's disease	0.00134	0.0158	CcSEcCtD
Trifluoperazine—Neuroleptic malignant syndrome—Memantine—Alzheimer's disease	0.00134	0.0158	CcSEcCtD
Trifluoperazine—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.00131	0.0155	CcSEcCtD
Trifluoperazine—Extrapyramidal symptoms—Rivastigmine—Alzheimer's disease	0.00129	0.0153	CcSEcCtD
Trifluoperazine—Ileus—Donepezil—Alzheimer's disease	0.00107	0.0126	CcSEcCtD
Trifluoperazine—EBPL—nervous system—Alzheimer's disease	0.00102	0.0185	CbGeAlD
Trifluoperazine—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.001	0.0118	CcSEcCtD
Trifluoperazine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000987	0.018	CbGeAlD
Trifluoperazine—EBPL—central nervous system—Alzheimer's disease	0.000977	0.0178	CbGeAlD
Trifluoperazine—Torsade de pointes—Memantine—Alzheimer's disease	0.000976	0.0115	CcSEcCtD
Trifluoperazine—Ileus—Memantine—Alzheimer's disease	0.000967	0.0114	CcSEcCtD
Trifluoperazine—EBPL—cerebellum—Alzheimer's disease	0.000955	0.0174	CbGeAlD
Trifluoperazine—Glycosuria—Donepezil—Alzheimer's disease	0.000931	0.011	CcSEcCtD
Trifluoperazine—CALY—nervous system—Alzheimer's disease	0.000928	0.0169	CbGeAlD
Trifluoperazine—Ventricular arrhythmia—Memantine—Alzheimer's disease	0.000925	0.0109	CcSEcCtD
Trifluoperazine—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.000909	0.0107	CcSEcCtD
Trifluoperazine—CALY—central nervous system—Alzheimer's disease	0.000894	0.0163	CbGeAlD
Trifluoperazine—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.000889	0.0105	CcSEcCtD
Trifluoperazine—HTR6—forebrain—Alzheimer's disease	0.000889	0.0162	CbGeAlD
Trifluoperazine—CALY—cerebellum—Alzheimer's disease	0.000874	0.0159	CbGeAlD
Trifluoperazine—HTR6—telencephalon—Alzheimer's disease	0.000817	0.0149	CbGeAlD
Trifluoperazine—CALM2—blood vessel—Alzheimer's disease	0.000805	0.0147	CbGeAlD
Trifluoperazine—CALM1—blood vessel—Alzheimer's disease	0.000802	0.0146	CbGeAlD
Trifluoperazine—EBPL—brain—Alzheimer's disease	0.000776	0.0141	CbGeAlD
Trifluoperazine—Gait disturbance—Donepezil—Alzheimer's disease	0.000773	0.00913	CcSEcCtD
Trifluoperazine—S100A4—cerebellum—Alzheimer's disease	0.000754	0.0138	CbGeAlD
Trifluoperazine—Dyskinesia—Memantine—Alzheimer's disease	0.000728	0.00861	CcSEcCtD
Trifluoperazine—Dyskinesia—Rivastigmine—Alzheimer's disease	0.000713	0.00842	CcSEcCtD
Trifluoperazine—CALY—brain—Alzheimer's disease	0.00071	0.0129	CbGeAlD
Trifluoperazine—Gait disturbance—Memantine—Alzheimer's disease	0.000701	0.00829	CcSEcCtD
Trifluoperazine—Gait disturbance—Rivastigmine—Alzheimer's disease	0.000686	0.00811	CcSEcCtD
Trifluoperazine—Urinary retention—Galantamine—Alzheimer's disease	0.000672	0.00794	CcSEcCtD
Trifluoperazine—Muscular weakness—Galantamine—Alzheimer's disease	0.000623	0.00736	CcSEcCtD
Trifluoperazine—S100A4—brain—Alzheimer's disease	0.000613	0.0112	CbGeAlD
Trifluoperazine—Dysphagia—Galantamine—Alzheimer's disease	0.00061	0.00722	CcSEcCtD
Trifluoperazine—Eczema—Donepezil—Alzheimer's disease	0.000609	0.0072	CcSEcCtD
Trifluoperazine—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.000606	0.00717	CcSEcCtD
Trifluoperazine—Increased appetite—Donepezil—Alzheimer's disease	0.000583	0.00689	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Donepezil—Alzheimer's disease	0.000561	0.00663	CcSEcCtD
Trifluoperazine—Eczema—Memantine—Alzheimer's disease	0.000553	0.00654	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Galantamine—Alzheimer's disease	0.000551	0.00651	CcSEcCtD
Trifluoperazine—Eczema—Rivastigmine—Alzheimer's disease	0.000541	0.0064	CcSEcCtD
Trifluoperazine—CHRM2—forebrain—Alzheimer's disease	0.000533	0.00972	CbGeAlD
Trifluoperazine—Increased appetite—Memantine—Alzheimer's disease	0.000529	0.00625	CcSEcCtD
Trifluoperazine—Urinary retention—Donepezil—Alzheimer's disease	0.00052	0.00615	CcSEcCtD
Trifluoperazine—Increased appetite—Rivastigmine—Alzheimer's disease	0.000517	0.00612	CcSEcCtD
Trifluoperazine—HTR2C—forebrain—Alzheimer's disease	0.000514	0.00937	CbGeAlD
Trifluoperazine—Hypoglycaemia—Memantine—Alzheimer's disease	0.000509	0.00602	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.000498	0.00589	CcSEcCtD
Trifluoperazine—CALM3—telencephalon—Alzheimer's disease	0.000498	0.00907	CbGeAlD
Trifluoperazine—CHRM2—telencephalon—Alzheimer's disease	0.00049	0.00894	CbGeAlD
Trifluoperazine—HTR2A—blood vessel—Alzheimer's disease	0.000488	0.00891	CbGeAlD
Trifluoperazine—Muscular weakness—Donepezil—Alzheimer's disease	0.000483	0.00571	CcSEcCtD
Trifluoperazine—HTR6—nervous system—Alzheimer's disease	0.000483	0.0088	CbGeAlD
Trifluoperazine—Oedema peripheral—Galantamine—Alzheimer's disease	0.000481	0.00569	CcSEcCtD
Trifluoperazine—CALM2—embryo—Alzheimer's disease	0.00048	0.00876	CbGeAlD
Trifluoperazine—CALM1—embryo—Alzheimer's disease	0.000478	0.00872	CbGeAlD
Trifluoperazine—Dysphagia—Donepezil—Alzheimer's disease	0.000473	0.00559	CcSEcCtD
Trifluoperazine—Asthma—Donepezil—Alzheimer's disease	0.000473	0.00559	CcSEcCtD
Trifluoperazine—Cardiac arrest—Memantine—Alzheimer's disease	0.000473	0.00559	CcSEcCtD
Trifluoperazine—Urinary retention—Memantine—Alzheimer's disease	0.000473	0.00559	CcSEcCtD
Trifluoperazine—HTR2C—telencephalon—Alzheimer's disease	0.000472	0.00861	CbGeAlD
Trifluoperazine—Eosinophilia—Donepezil—Alzheimer's disease	0.000468	0.00554	CcSEcCtD
Trifluoperazine—HTR6—central nervous system—Alzheimer's disease	0.000465	0.00847	CbGeAlD
Trifluoperazine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000462	0.00546	CcSEcCtD
Trifluoperazine—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000462	0.00546	CcSEcCtD
Trifluoperazine—SIGMAR1—telencephalon—Alzheimer's disease	0.000445	0.00811	CbGeAlD
Trifluoperazine—Muscular weakness—Memantine—Alzheimer's disease	0.000438	0.00518	CcSEcCtD
Trifluoperazine—HTR1A—forebrain—Alzheimer's disease	0.000432	0.00788	CbGeAlD
Trifluoperazine—Weight increased—Donepezil—Alzheimer's disease	0.00043	0.00509	CcSEcCtD
Trifluoperazine—Asthma—Memantine—Alzheimer's disease	0.000429	0.00508	CcSEcCtD
Trifluoperazine—Dysphagia—Memantine—Alzheimer's disease	0.000429	0.00508	CcSEcCtD
Trifluoperazine—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000429	0.00507	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000427	0.00504	CcSEcCtD
Trifluoperazine—CALM2—forebrain—Alzheimer's disease	0.000425	0.00775	CbGeAlD
Trifluoperazine—CALM1—forebrain—Alzheimer's disease	0.000423	0.00771	CbGeAlD
Trifluoperazine—Bronchospasm—Memantine—Alzheimer's disease	0.000422	0.00499	CcSEcCtD
Trifluoperazine—Dysphagia—Rivastigmine—Alzheimer's disease	0.00042	0.00497	CcSEcCtD
Trifluoperazine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000413	0.00489	CcSEcCtD
Trifluoperazine—Nervousness—Galantamine—Alzheimer's disease	0.000413	0.00488	CcSEcCtD
Trifluoperazine—Jaundice—Donepezil—Alzheimer's disease	0.000411	0.00486	CcSEcCtD
Trifluoperazine—Muscle spasms—Galantamine—Alzheimer's disease	0.000409	0.00483	CcSEcCtD
Trifluoperazine—Pancytopenia—Memantine—Alzheimer's disease	0.000408	0.00482	CcSEcCtD
Trifluoperazine—Vision blurred—Galantamine—Alzheimer's disease	0.000401	0.00474	CcSEcCtD
Trifluoperazine—ADRA1A—forebrain—Alzheimer's disease	0.000399	0.00727	CbGeAlD
Trifluoperazine—Tremor—Galantamine—Alzheimer's disease	0.000398	0.00471	CcSEcCtD
Trifluoperazine—HTR1A—telencephalon—Alzheimer's disease	0.000398	0.00725	CbGeAlD
Trifluoperazine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000396	0.00468	CcSEcCtD
Trifluoperazine—Weight increased—Memantine—Alzheimer's disease	0.000391	0.00462	CcSEcCtD
Trifluoperazine—Agitation—Galantamine—Alzheimer's disease	0.000391	0.00462	CcSEcCtD
Trifluoperazine—CALM2—telencephalon—Alzheimer's disease	0.000391	0.00712	CbGeAlD
Trifluoperazine—DRD2—forebrain—Alzheimer's disease	0.000391	0.00712	CbGeAlD
Trifluoperazine—CALM1—telencephalon—Alzheimer's disease	0.000389	0.00709	CbGeAlD
Trifluoperazine—Hyperglycaemia—Memantine—Alzheimer's disease	0.000387	0.00458	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000387	0.00457	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000384	0.00453	CcSEcCtD
Trifluoperazine—Weight increased—Rivastigmine—Alzheimer's disease	0.000382	0.00452	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000379	0.00448	CcSEcCtD
Trifluoperazine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000375	0.00443	CcSEcCtD
Trifluoperazine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000373	0.00441	CcSEcCtD
Trifluoperazine—Cough—Galantamine—Alzheimer's disease	0.000371	0.00439	CcSEcCtD
Trifluoperazine—HTR6—brain—Alzheimer's disease	0.000369	0.00673	CbGeAlD
Trifluoperazine—Convulsion—Galantamine—Alzheimer's disease	0.000368	0.00436	CcSEcCtD
Trifluoperazine—ADRA1A—telencephalon—Alzheimer's disease	0.000366	0.00668	CbGeAlD
Trifluoperazine—DRD2—telencephalon—Alzheimer's disease	0.000359	0.00655	CbGeAlD
Trifluoperazine—Agranulocytosis—Memantine—Alzheimer's disease	0.000357	0.00422	CcSEcCtD
Trifluoperazine—Dry mouth—Galantamine—Alzheimer's disease	0.000354	0.00419	CcSEcCtD
Trifluoperazine—Oedema peripheral—Memantine—Alzheimer's disease	0.000339	0.004	CcSEcCtD
Trifluoperazine—Skin disorder—Galantamine—Alzheimer's disease	0.000337	0.00399	CcSEcCtD
Trifluoperazine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000331	0.00392	CcSEcCtD
Trifluoperazine—Anorexia—Galantamine—Alzheimer's disease	0.000331	0.00391	CcSEcCtD
Trifluoperazine—Erythema—Donepezil—Alzheimer's disease	0.00033	0.0039	CcSEcCtD
Trifluoperazine—Hypotension—Galantamine—Alzheimer's disease	0.000324	0.00383	CcSEcCtD
Trifluoperazine—Nervousness—Donepezil—Alzheimer's disease	0.00032	0.00378	CcSEcCtD
Trifluoperazine—ABCB1—blood vessel—Alzheimer's disease	0.00032	0.00584	CbGeAlD
Trifluoperazine—Muscle spasms—Donepezil—Alzheimer's disease	0.000317	0.00375	CcSEcCtD
Trifluoperazine—Insomnia—Galantamine—Alzheimer's disease	0.000314	0.00371	CcSEcCtD
Trifluoperazine—Vision blurred—Donepezil—Alzheimer's disease	0.000311	0.00367	CcSEcCtD
Trifluoperazine—Tremor—Donepezil—Alzheimer's disease	0.000309	0.00365	CcSEcCtD
Trifluoperazine—Somnolence—Galantamine—Alzheimer's disease	0.000309	0.00365	CcSEcCtD
Trifluoperazine—HRH1—forebrain—Alzheimer's disease	0.000309	0.00563	CbGeAlD
Trifluoperazine—Agitation—Donepezil—Alzheimer's disease	0.000303	0.00358	CcSEcCtD
Trifluoperazine—Decreased appetite—Galantamine—Alzheimer's disease	0.000302	0.00357	CcSEcCtD
Trifluoperazine—Fatigue—Galantamine—Alzheimer's disease	0.000299	0.00354	CcSEcCtD
Trifluoperazine—Constipation—Galantamine—Alzheimer's disease	0.000297	0.00351	CcSEcCtD
Trifluoperazine—Erythema—Rivastigmine—Alzheimer's disease	0.000293	0.00346	CcSEcCtD
Trifluoperazine—HTR2A—embryo—Alzheimer's disease	0.000291	0.00531	CbGeAlD
Trifluoperazine—Nervousness—Memantine—Alzheimer's disease	0.000291	0.00344	CcSEcCtD
Trifluoperazine—CHRM2—nervous system—Alzheimer's disease	0.000289	0.00528	CbGeAlD
Trifluoperazine—Cough—Donepezil—Alzheimer's disease	0.000288	0.0034	CcSEcCtD
Trifluoperazine—Convulsion—Donepezil—Alzheimer's disease	0.000286	0.00338	CcSEcCtD
Trifluoperazine—Nervousness—Rivastigmine—Alzheimer's disease	0.000284	0.00336	CcSEcCtD
Trifluoperazine—HRH1—telencephalon—Alzheimer's disease	0.000284	0.00517	CbGeAlD
Trifluoperazine—Vision blurred—Memantine—Alzheimer's disease	0.000282	0.00333	CcSEcCtD
Trifluoperazine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000281	0.00333	CcSEcCtD
Trifluoperazine—Tremor—Memantine—Alzheimer's disease	0.00028	0.00331	CcSEcCtD
Trifluoperazine—HTR2C—nervous system—Alzheimer's disease	0.000279	0.00508	CbGeAlD
Trifluoperazine—CHRM2—central nervous system—Alzheimer's disease	0.000279	0.00508	CbGeAlD
Trifluoperazine—CALM3—cerebellum—Alzheimer's disease	0.000276	0.00504	CbGeAlD
Trifluoperazine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000276	0.00326	CcSEcCtD
Trifluoperazine—Agitation—Memantine—Alzheimer's disease	0.000275	0.00325	CcSEcCtD
Trifluoperazine—Dry mouth—Donepezil—Alzheimer's disease	0.000274	0.00324	CcSEcCtD
Trifluoperazine—Body temperature increased—Galantamine—Alzheimer's disease	0.000274	0.00324	CcSEcCtD
Trifluoperazine—Tremor—Rivastigmine—Alzheimer's disease	0.000274	0.00324	CcSEcCtD
Trifluoperazine—Agitation—Rivastigmine—Alzheimer's disease	0.000269	0.00318	CcSEcCtD
Trifluoperazine—HTR2C—central nervous system—Alzheimer's disease	0.000268	0.0049	CbGeAlD
Trifluoperazine—Leukopenia—Memantine—Alzheimer's disease	0.000268	0.00317	CcSEcCtD
Trifluoperazine—Cough—Memantine—Alzheimer's disease	0.000261	0.00309	CcSEcCtD
Trifluoperazine—Convulsion—Memantine—Alzheimer's disease	0.000259	0.00307	CcSEcCtD
Trifluoperazine—HTR2A—forebrain—Alzheimer's disease	0.000258	0.0047	CbGeAlD
Trifluoperazine—Anorexia—Donepezil—Alzheimer's disease	0.000256	0.00303	CcSEcCtD
Trifluoperazine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000256	0.00302	CcSEcCtD
Trifluoperazine—Cough—Rivastigmine—Alzheimer's disease	0.000255	0.00302	CcSEcCtD
Trifluoperazine—Convulsion—Rivastigmine—Alzheimer's disease	0.000254	0.003	CcSEcCtD
Trifluoperazine—Hypotension—Donepezil—Alzheimer's disease	0.000251	0.00297	CcSEcCtD
Trifluoperazine—Dry mouth—Memantine—Alzheimer's disease	0.000249	0.00295	CcSEcCtD
Trifluoperazine—Asthenia—Galantamine—Alzheimer's disease	0.000249	0.00294	CcSEcCtD
Trifluoperazine—SIGMAR1—cerebellum—Alzheimer's disease	0.000247	0.0045	CbGeAlD
Trifluoperazine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000244	0.00288	CcSEcCtD
Trifluoperazine—Insomnia—Donepezil—Alzheimer's disease	0.000243	0.00288	CcSEcCtD
Trifluoperazine—Dyspnoea—Donepezil—Alzheimer's disease	0.00024	0.00284	CcSEcCtD
Trifluoperazine—Somnolence—Donepezil—Alzheimer's disease	0.000239	0.00283	CcSEcCtD
Trifluoperazine—Skin disorder—Memantine—Alzheimer's disease	0.000237	0.0028	CcSEcCtD
Trifluoperazine—HTR2A—telencephalon—Alzheimer's disease	0.000237	0.00432	CbGeAlD
Trifluoperazine—HTR1A—nervous system—Alzheimer's disease	0.000235	0.00428	CbGeAlD
Trifluoperazine—Decreased appetite—Donepezil—Alzheimer's disease	0.000234	0.00276	CcSEcCtD
Trifluoperazine—Anorexia—Memantine—Alzheimer's disease	0.000233	0.00275	CcSEcCtD
Trifluoperazine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000232	0.00274	CcSEcCtD
Trifluoperazine—Fatigue—Donepezil—Alzheimer's disease	0.000232	0.00274	CcSEcCtD
Trifluoperazine—CALM2—nervous system—Alzheimer's disease	0.000231	0.00421	CbGeAlD
Trifluoperazine—Constipation—Donepezil—Alzheimer's disease	0.00023	0.00272	CcSEcCtD
Trifluoperazine—CALM1—nervous system—Alzheimer's disease	0.00023	0.00419	CbGeAlD
Trifluoperazine—Dizziness—Galantamine—Alzheimer's disease	0.00023	0.00271	CcSEcCtD
Trifluoperazine—Hypotension—Memantine—Alzheimer's disease	0.000228	0.0027	CcSEcCtD
Trifluoperazine—Anorexia—Rivastigmine—Alzheimer's disease	0.000228	0.00269	CcSEcCtD
Trifluoperazine—HTR1A—central nervous system—Alzheimer's disease	0.000226	0.00412	CbGeAlD
Trifluoperazine—Antrafenine—PTGS1—Alzheimer's disease	0.000225	0.0567	CrCbGaD
Trifluoperazine—CALM3—brain—Alzheimer's disease	0.000225	0.00409	CbGeAlD
Trifluoperazine—Hypotension—Rivastigmine—Alzheimer's disease	0.000223	0.00264	CcSEcCtD
Trifluoperazine—CALM2—central nervous system—Alzheimer's disease	0.000222	0.00405	CbGeAlD
Trifluoperazine—CHRM2—brain—Alzheimer's disease	0.000221	0.00403	CbGeAlD
Trifluoperazine—CALM1—central nervous system—Alzheimer's disease	0.000221	0.00403	CbGeAlD
Trifluoperazine—Insomnia—Memantine—Alzheimer's disease	0.000221	0.00261	CcSEcCtD
Trifluoperazine—HTR1A—cerebellum—Alzheimer's disease	0.000221	0.00403	CbGeAlD
Trifluoperazine—Rash—Galantamine—Alzheimer's disease	0.000219	0.00259	CcSEcCtD
Trifluoperazine—Dermatitis—Galantamine—Alzheimer's disease	0.000219	0.00258	CcSEcCtD
Trifluoperazine—Dyspnoea—Memantine—Alzheimer's disease	0.000218	0.00257	CcSEcCtD
Trifluoperazine—Headache—Galantamine—Alzheimer's disease	0.000217	0.00257	CcSEcCtD
Trifluoperazine—Somnolence—Memantine—Alzheimer's disease	0.000217	0.00257	CcSEcCtD
Trifluoperazine—CALM2—cerebellum—Alzheimer's disease	0.000217	0.00396	CbGeAlD
Trifluoperazine—ADRA1A—nervous system—Alzheimer's disease	0.000216	0.00395	CbGeAlD
Trifluoperazine—Insomnia—Rivastigmine—Alzheimer's disease	0.000216	0.00255	CcSEcCtD
Trifluoperazine—CALM1—cerebellum—Alzheimer's disease	0.000216	0.00394	CbGeAlD
Trifluoperazine—Urticaria—Donepezil—Alzheimer's disease	0.000214	0.00253	CcSEcCtD
Trifluoperazine—HTR2C—brain—Alzheimer's disease	0.000213	0.00389	CbGeAlD
Trifluoperazine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000213	0.00252	CcSEcCtD
Trifluoperazine—Body temperature increased—Donepezil—Alzheimer's disease	0.000213	0.00251	CcSEcCtD
Trifluoperazine—Somnolence—Rivastigmine—Alzheimer's disease	0.000212	0.00251	CcSEcCtD
Trifluoperazine—Decreased appetite—Memantine—Alzheimer's disease	0.000212	0.00251	CcSEcCtD
Trifluoperazine—DRD2—nervous system—Alzheimer's disease	0.000212	0.00387	CbGeAlD
Trifluoperazine—Fatigue—Memantine—Alzheimer's disease	0.000211	0.00249	CcSEcCtD
Trifluoperazine—Constipation—Memantine—Alzheimer's disease	0.000209	0.00247	CcSEcCtD
Trifluoperazine—ADRA1A—central nervous system—Alzheimer's disease	0.000208	0.0038	CbGeAlD
Trifluoperazine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000208	0.00246	CcSEcCtD
Trifluoperazine—Nausea—Galantamine—Alzheimer's disease	0.000206	0.00244	CcSEcCtD
Trifluoperazine—Fatigue—Rivastigmine—Alzheimer's disease	0.000206	0.00244	CcSEcCtD
Trifluoperazine—Constipation—Rivastigmine—Alzheimer's disease	0.000204	0.00242	CcSEcCtD
Trifluoperazine—DRD2—central nervous system—Alzheimer's disease	0.000204	0.00372	CbGeAlD
Trifluoperazine—ADRA1A—cerebellum—Alzheimer's disease	0.000204	0.00371	CbGeAlD
Trifluoperazine—SIGMAR1—brain—Alzheimer's disease	0.000201	0.00366	CbGeAlD
Trifluoperazine—DRD2—cerebellum—Alzheimer's disease	0.0002	0.00364	CbGeAlD
Trifluoperazine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000198	0.00234	CcSEcCtD
Trifluoperazine—Urticaria—Memantine—Alzheimer's disease	0.000194	0.00229	CcSEcCtD
Trifluoperazine—Body temperature increased—Memantine—Alzheimer's disease	0.000193	0.00228	CcSEcCtD
Trifluoperazine—Asthenia—Donepezil—Alzheimer's disease	0.000193	0.00228	CcSEcCtD
Trifluoperazine—ABCB1—embryo—Alzheimer's disease	0.000191	0.00348	CbGeAlD
Trifluoperazine—Pruritus—Donepezil—Alzheimer's disease	0.00019	0.00225	CcSEcCtD
Trifluoperazine—Urticaria—Rivastigmine—Alzheimer's disease	0.00019	0.00224	CcSEcCtD
Trifluoperazine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000189	0.00223	CcSEcCtD
Trifluoperazine—Hypersensitivity—Memantine—Alzheimer's disease	0.00018	0.00213	CcSEcCtD
Trifluoperazine—HTR1A—brain—Alzheimer's disease	0.000179	0.00327	CbGeAlD
Trifluoperazine—Dizziness—Donepezil—Alzheimer's disease	0.000178	0.0021	CcSEcCtD
Trifluoperazine—CALM2—brain—Alzheimer's disease	0.000176	0.00322	CbGeAlD
Trifluoperazine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000176	0.00208	CcSEcCtD
Trifluoperazine—CALM1—brain—Alzheimer's disease	0.000176	0.0032	CbGeAlD
Trifluoperazine—Asthenia—Memantine—Alzheimer's disease	0.000175	0.00207	CcSEcCtD
Trifluoperazine—Pruritus—Memantine—Alzheimer's disease	0.000173	0.00204	CcSEcCtD
Trifluoperazine—Asthenia—Rivastigmine—Alzheimer's disease	0.000171	0.00203	CcSEcCtD
Trifluoperazine—Rash—Donepezil—Alzheimer's disease	0.00017	0.00201	CcSEcCtD
Trifluoperazine—Zuclopenthixol—HTR6—Alzheimer's disease	0.00017	0.0427	CrCbGaD
Trifluoperazine—Dermatitis—Donepezil—Alzheimer's disease	0.000169	0.002	CcSEcCtD
Trifluoperazine—Pruritus—Rivastigmine—Alzheimer's disease	0.000169	0.002	CcSEcCtD
Trifluoperazine—ABCB1—forebrain—Alzheimer's disease	0.000169	0.00308	CbGeAlD
Trifluoperazine—Headache—Donepezil—Alzheimer's disease	0.000169	0.00199	CcSEcCtD
Trifluoperazine—HRH1—nervous system—Alzheimer's disease	0.000167	0.00305	CbGeAlD
Trifluoperazine—ADRA1A—brain—Alzheimer's disease	0.000165	0.00302	CbGeAlD
Trifluoperazine—DRD2—brain—Alzheimer's disease	0.000162	0.00296	CbGeAlD
Trifluoperazine—Dizziness—Memantine—Alzheimer's disease	0.000162	0.00191	CcSEcCtD
Trifluoperazine—HRH1—central nervous system—Alzheimer's disease	0.000161	0.00294	CbGeAlD
Trifluoperazine—Nausea—Donepezil—Alzheimer's disease	0.00016	0.00189	CcSEcCtD
Trifluoperazine—Dizziness—Rivastigmine—Alzheimer's disease	0.000158	0.00187	CcSEcCtD
Trifluoperazine—ABCB1—telencephalon—Alzheimer's disease	0.000155	0.00283	CbGeAlD
Trifluoperazine—Rash—Memantine—Alzheimer's disease	0.000154	0.00182	CcSEcCtD
Trifluoperazine—Dermatitis—Memantine—Alzheimer's disease	0.000154	0.00182	CcSEcCtD
Trifluoperazine—Headache—Memantine—Alzheimer's disease	0.000153	0.00181	CcSEcCtD
Trifluoperazine—Rash—Rivastigmine—Alzheimer's disease	0.000151	0.00178	CcSEcCtD
Trifluoperazine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000151	0.00178	CcSEcCtD
Trifluoperazine—Headache—Rivastigmine—Alzheimer's disease	0.00015	0.00177	CcSEcCtD
Trifluoperazine—Thiothixene—HTR6—Alzheimer's disease	0.000146	0.0368	CrCbGaD
Trifluoperazine—Nausea—Memantine—Alzheimer's disease	0.000145	0.00172	CcSEcCtD
Trifluoperazine—Mesoridazine—HTR6—Alzheimer's disease	0.000144	0.0363	CrCbGaD
Trifluoperazine—Nausea—Rivastigmine—Alzheimer's disease	0.000142	0.00168	CcSEcCtD
Trifluoperazine—Fluphenazine—CALM1—Alzheimer's disease	0.00014	0.0352	CrCbGaD
Trifluoperazine—HTR2A—nervous system—Alzheimer's disease	0.00014	0.00255	CbGeAlD
Trifluoperazine—HTR2A—central nervous system—Alzheimer's disease	0.000135	0.00246	CbGeAlD
Trifluoperazine—HTR2A—cerebellum—Alzheimer's disease	0.000132	0.0024	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—Alzheimer's disease	0.000129	0.0324	CrCbGaD
Trifluoperazine—HRH1—brain—Alzheimer's disease	0.000128	0.00233	CbGeAlD
Trifluoperazine—Fluphenazine—HTR6—Alzheimer's disease	0.000126	0.0318	CrCbGaD
Trifluoperazine—Clomipramine—HTR6—Alzheimer's disease	0.000116	0.0291	CrCbGaD
Trifluoperazine—Promethazine—CALM1—Alzheimer's disease	0.000113	0.0285	CrCbGaD
Trifluoperazine—Perphenazine—CALM1—Alzheimer's disease	0.000111	0.0279	CrCbGaD
Trifluoperazine—Thioridazine—HTR6—Alzheimer's disease	0.000109	0.0274	CrCbGaD
Trifluoperazine—HTR2A—brain—Alzheimer's disease	0.000107	0.00195	CbGeAlD
Trifluoperazine—Loxapine—HTR6—Alzheimer's disease	0.0001	0.0252	CrCbGaD
Trifluoperazine—Perphenazine—HTR6—Alzheimer's disease	9.99e-05	0.0251	CrCbGaD
Trifluoperazine—Ethopropazine—BCHE—Alzheimer's disease	9.83e-05	0.0247	CrCbGaD
Trifluoperazine—Quetiapine—HTR6—Alzheimer's disease	9.79e-05	0.0246	CrCbGaD
Trifluoperazine—ABCB1—nervous system—Alzheimer's disease	9.17e-05	0.00167	CbGeAlD
Trifluoperazine—Flupentixol—HTR2A—Alzheimer's disease	8.88e-05	0.0223	CrCbGaD
Trifluoperazine—ABCB1—central nervous system—Alzheimer's disease	8.83e-05	0.00161	CbGeAlD
Trifluoperazine—Chlorpromazine—CALM1—Alzheimer's disease	8.78e-05	0.0221	CrCbGaD
Trifluoperazine—ABCB1—cerebellum—Alzheimer's disease	8.63e-05	0.00157	CbGeAlD
Trifluoperazine—Clozapine—HTR6—Alzheimer's disease	8.43e-05	0.0212	CrCbGaD
Trifluoperazine—Triflupromazine—BCHE—Alzheimer's disease	8.05e-05	0.0203	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR6—Alzheimer's disease	7.92e-05	0.0199	CrCbGaD
Trifluoperazine—ABCB1—brain—Alzheimer's disease	7.01e-05	0.00128	CbGeAlD
Trifluoperazine—Cyamemazine—HTR2A—Alzheimer's disease	6.96e-05	0.0175	CrCbGaD
Trifluoperazine—Nefazodone—SLC6A4—Alzheimer's disease	6.45e-05	0.0162	CrCbGaD
Trifluoperazine—Trazodone—SLC6A4—Alzheimer's disease	5.97e-05	0.015	CrCbGaD
Trifluoperazine—Mequitazine—CYP2D6—Alzheimer's disease	5.53e-05	0.0139	CrCbGaD
Trifluoperazine—Zuclopenthixol—HTR2A—Alzheimer's disease	4.99e-05	0.0125	CrCbGaD
Trifluoperazine—Nefazodone—HTR2A—Alzheimer's disease	4.96e-05	0.0125	CrCbGaD
Trifluoperazine—Trazodone—HTR2A—Alzheimer's disease	4.59e-05	0.0115	CrCbGaD
Trifluoperazine—Zuclopenthixol—CYP2D6—Alzheimer's disease	4.56e-05	0.0115	CrCbGaD
Trifluoperazine—Nefazodone—CYP2D6—Alzheimer's disease	4.53e-05	0.0114	CrCbGaD
Trifluoperazine—Acepromazine—HTR2A—Alzheimer's disease	4.47e-05	0.0113	CrCbGaD
Trifluoperazine—Clomipramine—SLC6A4—Alzheimer's disease	4.42e-05	0.0111	CrCbGaD
Trifluoperazine—Thioproperazine—HTR2A—Alzheimer's disease	4.37e-05	0.011	CrCbGaD
Trifluoperazine—Pipotiazine—HTR2A—Alzheimer's disease	4.3e-05	0.0108	CrCbGaD
Trifluoperazine—Thiothixene—HTR2A—Alzheimer's disease	4.3e-05	0.0108	CrCbGaD
Trifluoperazine—Mesoridazine—HTR2A—Alzheimer's disease	4.24e-05	0.0107	CrCbGaD
Trifluoperazine—Trazodone—CYP2D6—Alzheimer's disease	4.2e-05	0.0106	CrCbGaD
Trifluoperazine—Thiothixene—CYP2D6—Alzheimer's disease	3.93e-05	0.00989	CrCbGaD
Trifluoperazine—Pipotiazine—CYP2D6—Alzheimer's disease	3.93e-05	0.00989	CrCbGaD
Trifluoperazine—Chlorpromazine—BCHE—Alzheimer's disease	3.89e-05	0.00978	CrCbGaD
Trifluoperazine—Mesoridazine—CYP2D6—Alzheimer's disease	3.88e-05	0.00976	CrCbGaD
Trifluoperazine—Loxapine—SLC6A4—Alzheimer's disease	3.84e-05	0.00966	CrCbGaD
Trifluoperazine—Prochlorperazine—CYP2D6—Alzheimer's disease	3.76e-05	0.00945	CrCbGaD
Trifluoperazine—Fluphenazine—HTR2A—Alzheimer's disease	3.72e-05	0.00935	CrCbGaD
Trifluoperazine—Propiomazine—HTR2A—Alzheimer's disease	3.57e-05	0.00899	CrCbGaD
Trifluoperazine—Clomipramine—HTR2A—Alzheimer's disease	3.4e-05	0.00855	CrCbGaD
Trifluoperazine—Fluphenazine—CYP2D6—Alzheimer's disease	3.4e-05	0.00855	CrCbGaD
Trifluoperazine—Thioridazine—HTR2A—Alzheimer's disease	3.2e-05	0.00806	CrCbGaD
Trifluoperazine—Clomipramine—CYP2D6—Alzheimer's disease	3.11e-05	0.00782	CrCbGaD
Trifluoperazine—Methotrimeprazine—HTR2A—Alzheimer's disease	3.06e-05	0.00769	CrCbGaD
Trifluoperazine—Promethazine—HTR2A—Alzheimer's disease	3.01e-05	0.00758	CrCbGaD
Trifluoperazine—Loxapine—HTR2A—Alzheimer's disease	2.95e-05	0.00743	CrCbGaD
Trifluoperazine—Perphenazine—HTR2A—Alzheimer's disease	2.94e-05	0.00739	CrCbGaD
Trifluoperazine—Thioridazine—CYP2D6—Alzheimer's disease	2.93e-05	0.00737	CrCbGaD
Trifluoperazine—Quetiapine—HTR2A—Alzheimer's disease	2.88e-05	0.00725	CrCbGaD
Trifluoperazine—Methotrimeprazine—CYP2D6—Alzheimer's disease	2.8e-05	0.00703	CrCbGaD
Trifluoperazine—Promethazine—CYP2D6—Alzheimer's disease	2.75e-05	0.00693	CrCbGaD
Trifluoperazine—Perphenazine—CYP2D6—Alzheimer's disease	2.69e-05	0.00676	CrCbGaD
Trifluoperazine—Promazine—HTR2A—Alzheimer's disease	2.65e-05	0.00666	CrCbGaD
Trifluoperazine—Quetiapine—CYP2D6—Alzheimer's disease	2.64e-05	0.00663	CrCbGaD
Trifluoperazine—Clozapine—HTR2A—Alzheimer's disease	2.48e-05	0.00624	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR2A—Alzheimer's disease	2.33e-05	0.00587	CrCbGaD
Trifluoperazine—Clozapine—CYP2D6—Alzheimer's disease	2.27e-05	0.0057	CrCbGaD
Trifluoperazine—Chlorpromazine—CYP2D6—Alzheimer's disease	2.13e-05	0.00536	CrCbGaD
Trifluoperazine—CALM2—Signaling Pathways—CCR5—Alzheimer's disease	2.03e-06	2.11e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCR5—Alzheimer's disease	2.03e-06	2.11e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.02e-06	2.1e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2e-06	2.09e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—INS—Alzheimer's disease	1.99e-06	2.08e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	1.99e-06	2.07e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.99e-06	2.07e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PPARG—Alzheimer's disease	1.99e-06	2.07e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	1.98e-06	2.07e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HTR2A—Alzheimer's disease	1.98e-06	2.07e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HTR2A—Alzheimer's disease	1.98e-06	2.07e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	1.98e-06	2.06e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NOS3—Alzheimer's disease	1.97e-06	2.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NOS3—Alzheimer's disease	1.97e-06	2.05e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	1.97e-06	2.05e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	1.97e-06	2.05e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	1.96e-06	2.04e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	1.96e-06	2.04e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—INS—Alzheimer's disease	1.96e-06	2.04e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	1.95e-06	2.03e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—INS—Alzheimer's disease	1.95e-06	2.03e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	1.95e-06	2.03e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	1.94e-06	2.02e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	1.94e-06	2.02e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—AKT1—Alzheimer's disease	1.94e-06	2.02e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	1.93e-06	2.01e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	1.93e-06	2.01e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	1.93e-06	2.01e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	1.93e-06	2.01e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	1.93e-06	2.01e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	1.92e-06	2e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PPARG—Alzheimer's disease	1.92e-06	2e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PPARG—Alzheimer's disease	1.92e-06	2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CALM1—Alzheimer's disease	1.91e-06	1.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—LEP—Alzheimer's disease	1.91e-06	1.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—APOE—Alzheimer's disease	1.91e-06	1.99e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	1.9e-06	1.98e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	1.89e-06	1.97e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	1.89e-06	1.97e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	1.89e-06	1.97e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—IL6—Alzheimer's disease	1.89e-06	1.97e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CAV1—Alzheimer's disease	1.89e-06	1.97e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—INS—Alzheimer's disease	1.88e-06	1.96e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—INS—Alzheimer's disease	1.88e-06	1.96e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL1B—Alzheimer's disease	1.88e-06	1.96e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—AKT1—Alzheimer's disease	1.87e-06	1.95e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—AKT1—Alzheimer's disease	1.87e-06	1.95e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PTGS2—Alzheimer's disease	1.86e-06	1.94e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	1.86e-06	1.94e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	1.86e-06	1.94e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.86e-06	1.93e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CALM1—Alzheimer's disease	1.85e-06	1.93e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—LEP—Alzheimer's disease	1.84e-06	1.92e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—APOE—Alzheimer's disease	1.84e-06	1.92e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—LEP—Alzheimer's disease	1.84e-06	1.92e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—APOE—Alzheimer's disease	1.84e-06	1.92e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—IL6—Alzheimer's disease	1.83e-06	1.9e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—IL6—Alzheimer's disease	1.83e-06	1.9e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CAV1—Alzheimer's disease	1.83e-06	1.9e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CAV1—Alzheimer's disease	1.83e-06	1.9e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ESR1—Alzheimer's disease	1.82e-06	1.9e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL1B—Alzheimer's disease	1.82e-06	1.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL1B—Alzheimer's disease	1.82e-06	1.89e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.81e-06	1.88e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTGS2—Alzheimer's disease	1.8e-06	1.88e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTGS2—Alzheimer's disease	1.8e-06	1.88e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.8e-06	1.87e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—F2—Alzheimer's disease	1.8e-06	1.87e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	1.78e-06	1.85e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ESR1—Alzheimer's disease	1.76e-06	1.83e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ESR1—Alzheimer's disease	1.76e-06	1.83e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NOTCH1—Alzheimer's disease	1.76e-06	1.83e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.75e-06	1.82e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—AKT1—Alzheimer's disease	1.74e-06	1.82e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—F2—Alzheimer's disease	1.74e-06	1.81e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—F2—Alzheimer's disease	1.74e-06	1.81e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.73e-06	1.81e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—APOE—Alzheimer's disease	1.73e-06	1.8e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—MAPK8—Alzheimer's disease	1.72e-06	1.79e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.72e-06	1.79e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.72e-06	1.79e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.71e-06	1.78e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—NOS3—Alzheimer's disease	1.71e-06	1.78e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.71e-06	1.78e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.7e-06	1.77e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.7e-06	1.77e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.7e-06	1.77e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.69e-06	1.76e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.69e-06	1.76e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—AKT1—Alzheimer's disease	1.69e-06	1.76e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—AKT1—Alzheimer's disease	1.69e-06	1.76e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.68e-06	1.75e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.68e-06	1.75e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.68e-06	1.75e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—AKT1—Alzheimer's disease	1.67e-06	1.74e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.67e-06	1.74e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—MAPK8—Alzheimer's disease	1.67e-06	1.74e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—MAPK8—Alzheimer's disease	1.67e-06	1.74e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—NOS3—Alzheimer's disease	1.65e-06	1.72e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—NOS3—Alzheimer's disease	1.65e-06	1.72e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—GSK3B—Alzheimer's disease	1.65e-06	1.72e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.65e-06	1.71e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CREB1—Alzheimer's disease	1.64e-06	1.71e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—INS—Alzheimer's disease	1.63e-06	1.7e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—AKT1—Alzheimer's disease	1.62e-06	1.69e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—AKT1—Alzheimer's disease	1.62e-06	1.69e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCL2—Alzheimer's disease	1.6e-06	1.67e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—GSK3B—Alzheimer's disease	1.6e-06	1.66e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—GSK3B—Alzheimer's disease	1.6e-06	1.66e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CREB1—Alzheimer's disease	1.58e-06	1.65e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CREB1—Alzheimer's disease	1.58e-06	1.65e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—INS—Alzheimer's disease	1.57e-06	1.64e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—INS—Alzheimer's disease	1.57e-06	1.64e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF1—Alzheimer's disease	1.57e-06	1.64e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—Alzheimer's disease	1.56e-06	1.63e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.55e-06	1.62e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCL2—Alzheimer's disease	1.55e-06	1.61e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCL2—Alzheimer's disease	1.55e-06	1.61e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.55e-06	1.61e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.55e-06	1.61e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.54e-06	1.61e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF1—Alzheimer's disease	1.52e-06	1.59e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF1—Alzheimer's disease	1.52e-06	1.59e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—Alzheimer's disease	1.51e-06	1.57e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—Alzheimer's disease	1.51e-06	1.57e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.5e-06	1.57e-05	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.5e-06	1.56e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.48e-06	1.55e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.48e-06	1.54e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—INS—Alzheimer's disease	1.48e-06	1.54e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.47e-06	1.54e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.47e-06	1.54e-05	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.47e-06	1.53e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.46e-06	1.53e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.46e-06	1.52e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.46e-06	1.52e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.45e-06	1.51e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.45e-06	1.51e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.45e-06	1.51e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.44e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.43e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.43e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.43e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NOS3—Alzheimer's disease	1.43e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.43e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.42e-06	1.48e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.42e-06	1.48e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.38e-06	1.44e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOS3—Alzheimer's disease	1.38e-06	1.44e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOS3—Alzheimer's disease	1.38e-06	1.44e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.38e-06	1.44e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.37e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.36e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.36e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFB1—Alzheimer's disease	1.35e-06	1.4e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.34e-06	1.4e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.34e-06	1.4e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.34e-06	1.4e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.34e-06	1.39e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.34e-06	1.39e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.32e-06	1.37e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.32e-06	1.37e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.31e-06	1.37e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.31e-06	1.37e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.31e-06	1.37e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.31e-06	1.36e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—Alzheimer's disease	1.3e-06	1.36e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—Alzheimer's disease	1.3e-06	1.36e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.29e-06	1.35e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.26e-06	1.31e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.24e-06	1.29e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.24e-06	1.29e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	1.29e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.22e-06	1.27e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.21e-06	1.26e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—Alzheimer's disease	1.21e-06	1.26e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—Alzheimer's disease	1.2e-06	1.25e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.2e-06	1.25e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.18e-06	1.23e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.18e-06	1.23e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—Alzheimer's disease	1.17e-06	1.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—Alzheimer's disease	1.17e-06	1.22e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—Alzheimer's disease	1.16e-06	1.21e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—Alzheimer's disease	1.16e-06	1.21e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.16e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.14e-06	1.18e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.13e-06	1.18e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.12e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.11e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.11e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.11e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—Alzheimer's disease	1.1e-06	1.15e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.08e-06	1.13e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.08e-06	1.12e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.08e-06	1.12e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.08e-06	1.12e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.07e-06	1.12e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.07e-06	1.12e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—Alzheimer's disease	1.06e-06	1.11e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—Alzheimer's disease	1.06e-06	1.11e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.03e-06	1.08e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.03e-06	1.07e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—Alzheimer's disease	1.02e-06	1.06e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—Alzheimer's disease	1.02e-06	1.06e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—Alzheimer's disease	9.95e-07	1.04e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—Alzheimer's disease	9.95e-07	1.04e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	9.92e-07	1.03e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	9.87e-07	1.03e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—Alzheimer's disease	9.83e-07	1.02e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—Alzheimer's disease	9.83e-07	1.02e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—Alzheimer's disease	9.82e-07	1.02e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—Alzheimer's disease	9.82e-07	1.02e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	9.52e-07	9.91e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	9.45e-07	9.84e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—Alzheimer's disease	9.44e-07	9.83e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—Alzheimer's disease	9.37e-07	9.76e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	9.36e-07	9.75e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	9.34e-07	9.73e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	9.19e-07	9.58e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	9.17e-07	9.55e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	9.15e-07	9.53e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—Alzheimer's disease	9.13e-07	9.51e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—Alzheimer's disease	9.13e-07	9.51e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	9.1e-07	9.48e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—Alzheimer's disease	9.07e-07	9.44e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—Alzheimer's disease	9.07e-07	9.44e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	8.71e-07	9.07e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	8.57e-07	8.93e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	8.55e-07	8.91e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	8.41e-07	8.77e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	8.39e-07	8.74e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	8.04e-07	8.37e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	7.91e-07	8.24e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	7.89e-07	8.22e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—Alzheimer's disease	7.85e-07	8.18e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—Alzheimer's disease	7.77e-07	8.1e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	7.76e-07	8.09e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	7.74e-07	8.06e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—Alzheimer's disease	7.59e-07	7.91e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—Alzheimer's disease	7.59e-07	7.91e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—Alzheimer's disease	7.52e-07	7.83e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—Alzheimer's disease	7.52e-07	7.83e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—Alzheimer's disease	7.11e-07	7.41e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—Alzheimer's disease	6.88e-07	7.17e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—Alzheimer's disease	6.88e-07	7.17e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—Alzheimer's disease	6.56e-07	6.84e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—Alzheimer's disease	6.35e-07	6.61e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—Alzheimer's disease	6.35e-07	6.61e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.95e-07	6.2e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.75e-07	4.95e-06	CbGpPWpGaD
